世界の非侵襲的出生前検査市場2021-2028:妊娠期間別、リスクタイプ別、方法別、技術別、製品別、最終用途別

◆英語タイトル:Non Invasive Prenatal Testing Market Size, Share & Trends Analysis Report By Gestation Period, By Risk Type, By Method, By Technology, By Product, By End-use, And Segment Forecasts, 2021 - 2028
◆商品コード:GV21MC091
◆発行会社(リサーチ会社):Grand View Research
◆発行日:2021年1月21日
◆ページ数:150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD5,950 ⇒換算¥684,250見積依頼/購入/質問フォーム
Multi User/Five UserUSD6,950 ⇒換算¥799,250見積依頼/購入/質問フォーム
Global/corporate LicenseUSD8,950 ⇒換算¥1,029,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGrand View Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Grand View Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

グランドビューリサーチ社は、世界の非侵襲的出生前検査市場規模が年平均10.9%成長し、2028年までに65億ドルに達すると予測しています。本調査レポートでは、非侵襲的出生前検査の世界市場について調査・分析し、調査手法・範囲、エグゼクティブサマリー、市場変動・動向・範囲、妊娠期間別(0〜12週、13〜24週、25〜36週)分析、リスクタイプ別(高リスク・平均リスク妊娠検査、低リスク妊娠検査)分析、方法別(超音波検出、生化学的スクリーニングテスト、母体血漿検査における無細胞DNA)分析、技術別(次世代シーケンシング(Ngs)、アレイテクノロジー、ポリメラーゼ連鎖反応(Pcr)、その他)分析、製品別(消耗品・試薬、器具)分析、最終用途別(病院・診療所、診断研究所)分析、地域別分析、競争分析などを掲載しています。
・調査手法・範囲
・エグゼクティブサマリー
・市場変動・動向・範囲
・非侵襲的出生前検査の世界市場規模:妊娠期間別(0〜12週、13〜24週、25〜36週)
・非侵襲的出生前検査の世界市場規模:リスクタイプ別(高リスク・平均リスク妊娠検査、低リスク妊娠検査)
・非侵襲的出生前検査の世界市場規模:方法別(超音波検出、生化学的スクリーニングテスト、母体血漿検査における無細胞DNA)
・非侵襲的出生前検査の世界市場規模:技術別(次世代シーケンシング(Ngs)、アレイテクノロジー、ポリメラーゼ連鎖反応(Pcr)、その他)
・非侵襲的出生前検査の世界市場規模:製品別(消耗品・試薬、器具)
・非侵襲的出生前検査の世界市場規模:最終用途別(病院・診療所、診断研究所)
・非侵襲的出生前検査の世界市場規模:地域別
・競争分析
【レポートの概要】

Non-invasive Prenatal Testing Market Growth & Trends

The global non invasive prenatal testing market size is anticipated to reach USD 6.5 billion by 2028 registering a CAGR of 10.9%, according to a new report by Grand View Research, Inc. High adoption and demand for early non-invasive prenatal testing (NIPT) coupled with improvements in reimbursement scenario are among the factors driving the market.

The use of invasive techniques of prenatal testing, such as chorionic villus sampling and amniocentesis, can lead to issues, such as miscarriage. This has led to a decline in the use of these procedures and high demand for tests that are more efficient, non-invasive, and safe. Furthermore, non-invasive fetal tests have a lower failure and false-positive rate, which has resulted in a considerable increase in uptake of non-invasive tests in the last few years.

The non-invasive prenatal testing market is highly saturated with the existing key players. Companies are forming partnerships and collaborations to maintain a stable position in the market. For instance, in August 2020, Eurofins Scientific announced an agreement with Noritsu Koki Co., Ltd. for the acquisition of GeneTech Inc., one of the pioneering NIPT developers in Japan. With this acquisition, Eurofins Scientific is set to strengthen its presence in the Japanese NIPT market.

Non-invasive Prenatal Testing Market Report Highlights

• The 13-24 weeks gestation period segment accounted for the largest revenue share in 2020 owing to the presence of a maximum number of tests carried out in this phase of pregnancy

• NIPT for high- & average-risk pregnancy led the market owing to the presence of favorable payer reimbursement policies in this segment

• Next-Generation Sequencing (NGS) is estimated to be the largest as well as the fastest-growing technology segment from 2021 to 2028, as NGS is the most commonly used method for NIPT

• The diagnostic laboratories end-use segment held the largest revenue share in 2020 and will expand further at the fastest CAGR from 2021 to 2028 due to the rising number of diagnostic laboratories across the globe that offer NIPT

• Asia Pacific is expected to register the fastest year-on-year growth owing to the gradually increasing average maternal age and rising incidence of chromosomal aneuploidies

• One of the key trends followed by market participants includes licensing of the test to other labs and generating significant revenue by collecting royalty payments

【レポートの目次】

Table of Contents

Chapter 1 Methodology and Scope
1.1 Market Segmentation and Scope
1.1.1 Segment scope
1.1.2 Regional scope
1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased database:
1.3.2 GVR’s internal database
1.3.3 Secondary sources
1.3.4 Primary research
1.3.5 Details of primary research
1.4 Information or Data Analysis
1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis
1.6.1.1 Approach: Commodity Flow Approach
1.7 List of Secondary Sources
1.8 List of Abbreviations
1.9 Objectives
1.9.1 Objective 1
1.9.2 Objective 2
1.9.3 Objective 3
1.9.4 Objective 4
Chapter 2 Executive Summary
2.1 Market Summary
Chapter 3 Non-Invasive Prenatal Testing (NIPT) Market Variables, Trends & Scope
3.1 Market Driver Analysis
3.1.1 Increasing average maternal age and rising incidence of chromosomal syndromes
3.1.2 High demand for early and non-invasive fetal testing procedure
3.1.3 Improvements in the reimbursement scenario
3.1.4 Rising collaborations and licensing agreements
3.2 Market Restraint Analysis
3.2.1 Ethical concerns with respect to reproductive genetics
3.2.2 High pricing
3.3 PEST Analysis
3.4 Porter’s Five Forces Analysis
3.5 Penetration and Growth Prospect Mapping
3.5.1 User Perspective analysis
3.5.1.1 Consumer behavior analysis
3.6 Regulatory Framework
3.7 COVID-19 Impact Analysis
3.7.1 Impact on the supply chain
3.7.2 Impact on assisted reproductive technology (ART) Services
3.7.3 Conclusion
Chapter 4 Non-Invasive Prenatal Testing (NIPT) Market: Gestation Period Business Analysis
4.1 NIPT Market: Gestation Period Movement Analysis
4.2 0-12 Weeks
4.3.1 0-12 weeks market estimates and forecast, 2017 – 2028 (USD Million)
4.3 13-24 Weeks
4.4.1 13-24 weeks market estimates and forecast, 2017 – 2028 (USD Million)
4.4 25-36 Weeks
4.5.1 25-36 weeks market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 5 Non-Invasive Prenatal Testing (NIPT) Market: Risk Type Business Analysis
5.1 NIPT Market: Risk Type Movement Analysis
5.2 High & Average Risk Pregnancy Testing
5.2.1 High & Average Risk Pregnancy Market Estimates And Forecast, 2017 – 2028 (USD Million)
5.3 Low Risk Pregnancy Testing
5.3.1 Low Risk Pregnancy Market Estimates And Forecast, 2017 – 2028 (USD Million)
Chapter 6 Method Business Analysis
6.1 NIPT Market: Method Movement Analysis
6.2 Ultrasound Detection
6.2.1 Ultrasound Detection-based NIPT market estimates and forecast, 2017 – 2028 (USD Million)
6.3 Biochemical Screening Tests
6.3.1 Biochemical Screening Tests-based NIPT market estimates and forecast, 2017 – 2028 (USD Million)
6.4 Cell-Free DNA in Maternal Plasma Tests
6.4.1 Cell-Free DNA in Maternal Plasma Tests market estimates and forecast, 2017 – 2028 (USD Million)
Chapter 7 Non-Invasive Prenatal Testing (NIPT) Market: Technology Business Analysis
7.1 NIPT Market: Technology Movement Analysis
7.2 Next-Generation Sequencing (Ngs)
7.2.1 Global NIPT Market For Ngs, 2017 – 2028 ((USD Million))
7.3 Array Technology
7.3.1 Global NIPT Market For Array Technology, 2017 – 2028 ((USD Million))
7.4 Polymerase Chain Reaction (Pcr)
7.4.1 Global NIPT Market For Pcr, 2017 – 2028 ((USD Million))
7.5 Other Technologies
7.5.1 Global NIPT Market For Other Technologies, 2017 – 2028 ((USD Million))
Chapter 8 Non-Invasive Prenatal Testing (NIPT) Market: Product Business Analysis
8.1 NIPT market: Product Movement Analysis
8.2 Consumables & Reagents
8.2.1 Global NIPT Consumables & Reagents market, 2017 – 2028 ((USD Million))
8.3 Instruments
8.3.1 Global NIPT Instruments market, 2017 – 2028 ((USD Million))
Chapter 9 Non-Invasive Prenatal Testing (NIPT) Market: End-Use Business Analysis
9.1 NIPT Market: End-Use Movement Analysis
9.2 Hospitals & Clinics
9.2.1 Global NIPT Market For Hospitals & Clinics, 2017 – 2028 ((USD Million))
9.3 Diagnostic Laboratories
9.3.1 Global NIPT Market For Diagnostic Laboratories, 2017 – 2028 ((USD Million))
Chapter 10 Non-Invasive Prenatal Testing (NIPT) Market: Regional Business Analysis
10.1 NIPT Market: Regional Movement Analysis
10.2 North America
10.2.1 North America market estimates and forecast, 2017 – 2028 (USD Million)
10.2.2 The U.S.
10.2.2.1 The U.S. market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.2.2.2 The U.S. market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.2.2.3 The U.S. market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.2.2.4 The U.S. market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.2.2.5 The U.S. market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.2.2.6 The U.S. market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.2.3 Canada
10.2.3.1 Canada market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.2.3.2 Canada market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.2.3.3 Canada market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.2.3.4 Canada market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.2.3.5 Canada market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.2.3.6 Canada market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.3 Europe
10.3.1 Europe market estimates and forecast, 2017 – 2028 (USD Million)
10.3.2 Germany
10.3.2.1 Germany market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.3.2.2 Germany market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.3.2.3 Germany market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.3.2.4 Germany market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.3.2.5 Germany market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.3.2.6 Germany market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.3.3 The U.K.
10.3.3.1 The U.K. market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.3.3.2 The U.K. market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.3.3.3 The U.K. market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.3.3.4 The U.K. market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.3.3.5 The U.K. market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.3.3.6 The U.K. market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.3.4 France
10.3.4.1 France market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.3.4.2 France market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.3.4.3 France market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.3.4.4 France market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.3.4.5 France market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.3.4.6 France market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.3.5 Italy
10.3.5.1 Italy market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.3.5.2 Italy market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.3.5.3 Italy market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.3.5.4 Italy market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.3.5.5 Italy market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.3.5.6 Italy market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.3.6 Spain
10.3.6.1 Spain market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.3.6.2 Spain market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.3.6.3 Spain market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.3.6.4 Spain market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.3.6.5 Spain market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.3.6.6 Spain market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.4 Asia Pacific
10.4.1 Asia Pacific market estimates and forecast, 2017 – 2028 (USD Million)
10.4.2 Japan
10.4.2.1 Japan market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.4.2.2 Japan market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.4.2.3 Japan market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.4.2.4 Japan market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.4.2.5 Japan market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.4.2.6 Japan market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.4.3 China
10.4.3.1 China market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.4.3.2 China market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.4.3.3 China market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.4.3.4 China market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.4.3.5 China market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.4.3.6 China market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.4.4 India
10.4.4.1 India market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.4.4.2 India market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.4.4.3 India market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.4.4.4 India market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.4.4.5 India market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.4.4.6 India market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.4.5 Singapore
10.4.5.1 Singapore market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.4.5.2 Singapore market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.4.5.3 Singapore market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.4.5.4 Singapore market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.4.5.5 Singapore market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.4.5.6 Singapore market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.4.6 Australia
10.4.6.1 Australia market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.4.6.2 Australia market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.4.6.3 Australia market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.4.6.4 Australia market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.4.6.5 Australia market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.4.6.6 Australia market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.5 Latin America
10.5.1 Latin America market estimates and forecast, 2017 – 2028 (USD Million)
10.5.2 Brazil
10.5.2.1 Brazil market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.5.2.2 Brazil market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.5.2.3 Brazil market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.5.2.4 Brazil market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.5.2.5 Brazil market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.5.2.6 Brazil market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.5.3 Mexico
10.5.3.1 Mexcio market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.5.3.2 Mexcio market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.5.3.3 Mexcio market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.5.3.4 Mexcio market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.5.3.5 Mexcio market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.5.3.6 Mexcio market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.6 MEA
10.6.1 MEA market estimates and forecast, 2017 – 2028 (USD Million)
10.6.2 South Africa
10.6.2.1 South Africa market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.6.2.2 South Africa market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.6.2.3 South Africa market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.6.2.4 South Africa market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.6.2.5 South Africa market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.6.2.6 South Africa market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
10.6.3 Saudi Arabia
10.6.3.1 Saudi Arabia market estimates and forecast, by gestation period, 2017 – 2028 (USD Million)
10.6.3.2 Saudi Arabia market estimates and forecast, by risk type, 2017 – 2028 (USD Million)
10.6.3.3 Saudi Arabia market estimates and forecast, by method, 2017 – 2028 (USD Million)
10.6.3.4 Saudi Arabia market estimates and forecast, by technology, 2017 – 2028 (USD Million)
10.6.3.5 Saudi Arabia market estimates and forecast, by product, 2017 – 2028 (USD Million)
10.6.3.6 Saudi Arabia market estimates and forecast, by end-use, 2017 – 2028 (USD Million)
Chapter 11 Non-Invasive Prenatal Testing (NIPT) Market: Competitive Analysis
11.1 Recent Developments & Impact Analysis, by Key Market Participants
11.1.1 Ansoff matrix
11.2 Company Categorization
11.2.1 Innovators
11.2.2 Market Leaders
11.3 Vendor Landscape
11.3.1 List of key distributors and channel partners
11.3.2 Key customers
11.3.3 List of key emerging companies
11.4 Synergy Analysis: Major Deals & Strategic Alliances
11.4.1 New Product Launch
11.4.2 Acquisition
11.4.3 Expansion
11.4.4 Partnerships
11.4.5 Marketing & Promotions
11.5 Company Profiles
11.5.1 Genesis Genetics (CooperSurgical Inc.)
11.5.1.1 Company overview
11.5.1.2 Financial performance
11.5.1.3 Product benchmarking
11.5.1.4 Strategic initiatives
11.5.2 Natera Inc.
11.5.2.1 Company overview
11.5.2.2 Financial performance
11.5.2.3 Product benchmarking
11.5.2.4 Strategic initiatives
11.5.3 Centogene N.V.
11.5.3.1 Company overview
11.5.3.2 Financial performance
11.5.3.3 Product benchmarking
11.5.3.4 Strategic initiatives
11.5.4 Illumina Inc (Verinata Health Inc.)
11.5.4.1 Company overview
11.5.4.2 Financial performance
11.5.4.3 Product benchmarking
11.5.4.4 Strategic initiatives
11.5.5 Eurofins LifeCodexx GmbH
11.5.5.1 Company overview
11.5.5.2 LifeCodexx AG
11.5.5.3 Financial performance
11.5.5.4 Product benchmarking
11.5.5.5 Strategic initiatives
11.5.6 MedGenome Labs Ltd.
11.5.6.1 Company overview
11.5.6.2 Product benchmarking
11.5.6.3 Strategic initiatives
11.5.7 F. Hoffmann-La Roche Ltd. (Ariosa Diagnostics)
11.5.7.1 Company overview
11.5.7.2 Financial performance
11.5.7.3 Product benchmarking
11.5.7.4 Strategic initiatives
11.5.8 Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.)
11.5.8.1 Company overview
11.5.8.2 Financial performance
11.5.8.3 Product benchmarking
11.5.8.4 Strategic initiatives
11.5.9 Progenity, Inc.
11.5.9.1 Company overview
11.5.9.2 Financial performance
11.5.9.3 Product benchmarking
11.5.9.4 Strategic initiatives
11.5.10 QIAGEN
11.5.10.1 Company overview
11.5.10.2 Financial performance
11.5.10.3 Product benchmarking
11.5.10.4 Strategic initiatives
11.5.11 LABORATORY CORP OF AMERICA HOLDINGS
11.5.11.1 Company overview
11.5.11.2 Sequenom
11.5.11.3 Integrated Genomics
11.5.11.4 Financial performance
11.5.11.5 Product benchmarking
11.5.11.6 Strategic initiatives
11.5.12 Quest Diagnostics Incorporated
11.5.12.1 Company overview
11.5.12.2 Financial performance
11.5.12.3 Product benchmarking
11.5.12.4 Strategic initiatives

List of Tables

TABLE 1 List of secondary sources
TABLE 2 List of abbreviations
TABLE 3 Risk of Trisomy 21 and chromosomal abnormalities with maternal age
TABLE 4 Global incidence rate of genetic disorders
TABLE 5 Commercial landscape of NIPT for fetal aneuploidy in the U.S.
TABLE 6 Average selling prices of non-invasive prenatal tests
TABLE 7 Regulatory framework
TABLE 8 Reported research studies that have used NGS for NIPT, as of 2017
TABLE 9 North America non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 10 North America non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 11 North America non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 12 North America non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 13 North America non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 14 North America non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 15 The U.S. non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 16 The U.S. non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 17 The U.S. non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 18 The U.S. non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 19 The U.S. non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 20 The U.S. non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 21 Canada non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 22 Canada non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 23 Canada non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 24 Canada non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 25 Canada non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 26 Canada non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 27 Europe non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 28 Europe non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 29 Europe non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 30 Europe non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 31 Europe non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 32 Europe non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 33 Germany non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 34 Germany non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 35 Germany non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 36 Germany non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 37 Germany non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 38 Germany non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 39 The U.K. non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 40 The U.K. non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 41 The U.K. non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 42 The U.K. non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 43 The U.K. non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 44 The U.K. non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 45 France non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 46 France non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 47 France non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 48 France non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 49 France non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 50 France non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 51 Spain non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 52 Spain non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 53 Spain non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 54 Spain non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 55 Spain non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 56 Spain non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 57 France non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 58 France non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 59 France non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 60 France non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 61 France non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 62 France non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 63 Asia Pacific non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 64 Asia Pacific non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 65 Asia Pacific non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 66 Asia Pacific non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 67 Asia Pacific non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 68 Asia Pacific non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 69 Japan non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 70 Japan non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 71 Japan non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 72 Japan non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 73 Japan non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 74 Japan non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 75 China non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 76 China non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 77 China non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 78 China non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 79 China non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 80 China non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 81 India non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 82 India non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 83 India non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 84 India non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 85 India non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 86 India non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 87 Australia non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 88 Australia non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 89 Australia non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 90 Australia non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 91 Australia non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 92 Australia non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 93 Singapore non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 94 Singapore non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 95 Singapore non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 96 Singapore non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 97 Singapore non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 98 Singapore non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 99 Latin America non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 100 Latin America non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 101 Latin America non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 102 Latin America non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 103 Latin America non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 104 Latin America non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 105 Brazil non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 106 Brazil non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 107 Brazil non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 108 Brazil non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 109 Brazil non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 110 Brazil non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 111 Mexico non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 112 Mexico non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 113 Mexico non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 114 Mexico non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 115 Mexico non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 116 Mexico non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 117 MEA non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 118 MEA non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 119 MEA non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 120 MEA non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 121 MEA non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 122 MEA non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 123 South Africa non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 124 South Africa non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 125 South Africa non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 126 South Africa non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 127 South Africa non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 128 South Africa non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 129 Saudi Arabia non-invasive prenatal testing market estimates & forecasts, by gestation period, 2017 - 2028 (USD Million)
TABLE 130 Saudi Arabia non-invasive prenatal testing market estimates & forecasts, by risk type, 2017 - 2028 (USD Million)
TABLE 131 Saudi Arabia non-invasive prenatal testing market estimates & forecasts, by method, 2017 - 2028 (USD Million)
TABLE 132 Saudi Arabia non-invasive prenatal testing market estimates & forecasts, by technology, 2017 - 2028 (USD Million)
TABLE 133 Saudi Arabia non-invasive prenatal testing market estimates & forecasts, by product, 2017 - 2028 (USD Million)
TABLE 134 Saudi Arabia non-invasive prenatal testing market estimates & forecasts, by end-use, 2017 - 2028 (USD Million)
TABLE 135 Leading market players anticipated to witness highest growth

List of Figures

FIG. 1 Non-invasive prenatal testing market segmentation
FIG. 2 Technology comparison
FIG. 3 Market research process
FIG. 4 Information procurement
FIG. 5 Primary research pattern
FIG. 6 Market research approaches
FIG. 7 Value-chain-based sizing & forecasting
FIG. 8 QFD modeling for market share assessment
FIG. 9 Market formulation & validation
FIG. 10 Penetration of NIPT market, U.S.
FIG. 11 NIPT market snapshot, (USD Million), 2020
FIG. 12 NIPT market driver impact
FIG. 13 Average age for the first child
FIG. 14 Reduction in the number of expensive and risky invasive amniocentesis and CVS procedures with rise in the number of NIPS procedures
FIG. 15 NIPT market restraint impact
FIG. 16 PEST analysis, by factor (political & legal, economic, and technological)
FIG. 17 Porter’s Five Forces Analysis
FIG. 18 Penetration and growth prospect mapping
FIG. 19 Consumer Behavior Analysis
FIG. 20 Key macroeconomic challenges associated with the pandemic
FIG. 21 Key elements to enhance the supply chain post COVID
FIG. 22 NIPT market: Gestation period outlook and key takeaways
FIG. 23 NIPT market: Gestation period movement analysis
FIG. 24 0-12 weeks market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 25 13-24 weeks market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 26 25-36 weeks market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 27 NIPT market: Risk type outlook and key takeaways
FIG. 28 NIPT market: Risk type movement analysis
FIG. 29 High & average risk pregnancy market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 30 Low risk pregnancy market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 31 NIPT market: Method outlook and key takeaways
FIG. 32 NIPT market: Method movement analysis
FIG. 33 Ultrasound detection-based NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 34 Biochemical screening tests-based NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 35 Cell-Free DNA in maternal plasma tests market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 36 NIPT market: Technology outlook and key takeaways
FIG. 37 Factors that facilitate the use of NIPT-NGS
FIG. 38 NIPT market: Technology movement analysis
FIG. 39 Global NIPT market for NGS, 2017 - 2028 ((USD Million))
FIG. 40 Global NIPT market for array technology, 2017 - 2028 ((USD Million))
FIG. 41 Global NIPT market for PCR, 2017 - 2028 ((USD Million))
FIG. 42 Global NIPT market for other technologies, 2017 - 2028 ((USD Million))
FIG. 43 NIPT market: Product outlook and key takeaways
FIG. 44 NIPT market: Product movement analysis
FIG. 45 Global NIPT consumables & reagents market, 2017 - 2028 ((USD Million))
FIG. 46 Components of Vanadis NIPT System
FIG. 47 Global NIPT instruments market, 2017 - 2028 ((USD Million))
FIG. 48 NIPT market: End-use outlook and key takeaways
FIG. 49 Number of laboratories performing various volumes of clinical NIPT tests per month in Europe
FIG. 50 NIPT market: End-use movement analysis
FIG. 51 Global NIPT market for hospitals & clinics, 2017 - 2028 ((USD Million))
FIG. 52 Global NIPT market for diagnostic laboratories, 2017 - 2028 ((USD Million))
FIG. 53 NIPT market: Regional outlook and key takeaways
FIG. 54 NIPT market: Regional movement analysis
FIG. 55 North America
FIG. 56 North America NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 57 The U.S.
FIG. 58 The U.S. NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 59 Canada
FIG. 60 Canada NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 61 Europe
FIG. 62 Europe NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 63 Germany
FIG. 64 Germany NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 65 The U.K.
FIG. 66 The U.K. NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 67 France
FIG. 68 France NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 69 Spain
FIG. 70 Spain NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 71 France
FIG. 72 France NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 73 Asia Pacific
FIG. 74 Asia Pacific NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 75 Japan
FIG. 76 Japan NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 77 China
FIG. 78 China NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 79 India
FIG. 80 India NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 81 Australia
FIG. 82 Australia NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 83 Singapore
FIG. 84 Singapore NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 85 Latin America
FIG. 86 Latin America NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 87 Brazil
FIG. 88 Brazil NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 89 Mexico
FIG. 90 Mexico NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 91 MEA
FIG. 92 MEA NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 93 South Africa
FIG. 94 South Africa NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 95 Saudi Arabia
FIG. 96 Saudi Arabia NIPT market estimates and forecast, 2017 - 2028 (USD Million)
FIG. 97 Ansoff Matrix
FIG. 98 Strategy mapping

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の非侵襲的出生前検査市場2021-2028:妊娠期間別、リスクタイプ別、方法別、技術別、製品別、最終用途別]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆